Gambia National Medicines Policy 2022 - 2025

CONTENT

The National Medicines Policy (2022–2025) of The Gambia aims to ensure equitable access to high-quality, affordable, and safe medicines for all citizens. It focuses on promoting rational use of medicines, strengthening pharmaceutical systems, and aligning with universal health coverage goals.

Specific Objectives

1. Access to Medicines: Ensure availability and affordability of essential medicines across the country.

2. Quality Assurance: Strengthen regulatory frameworks to guarantee the safety and efficacy of medicines.

3. Rational Use: Promote appropriate prescribing, dispensing, and use of medicines.

4. Capacity Building: Enhance technical expertise and infrastructure in the pharmaceutical sector.

5. Supply Chain Management: Improve procurement, storage, and distribution systems to prevent stockouts.

6. Policy Integration: Align the medicines policy with broader health sector priorities and international standards.

Summary 

The National Medicines Policy (2022–2025) provides a strategic framework for addressing challenges in The Gambia's pharmaceutical sector. It emphasizes equitable access to essential medicines, quality assurance, and rational use to improve health outcomes. The policy integrates public health and economic considerations, aiming to create resilient systems capable of coping with epidemics and growing health needs.

Key measures include:

• Strengthening regulatory bodies like the Medicines Control Agency (MCA).

• Promoting local manufacturing and reliable supply chains.

• Enhancing training programs for healthcare professionals.

• Implementing monitoring systems to track medicine usage and prevent misuse.

The policy aligns with the National Health Policy (2021–2030) and global health goals, ensuring that medicines contribute to universal health coverage and sustainable development.